Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
12.43
-1.35%
After-hours: Aug 15, 2025, 04:40 PM EDT

Cadrenal Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
1.88K 1.98K 1.27K
Gross Profit
-1.88K -1.98K -1.27K
Operating Income
-10.96M -7.63M -2.7M
Interest Income
309.25K 249.09K n/a
Pretax Income
-10.65M -8.36M -6.71M
Net Income
-10.65M -8.36M -6.71M
Selling & General & Admin
6.75M 3.55M 2.31M
Research & Development
4.21M 4.08M 392.86K
Other Expenses
1.88K n/a n/a
Operating Expenses
10.96M 7.63M 2.7M
Interest Expense
n/a 17.1K 107.11K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
10.96M 7.63M 2.7M
Income Tax Expense
n/a n/a 4.00
Shares Outstanding (Basic)
1.22M 868.18K 775.64K
Shares Outstanding (Diluted)
1.22M 868.18K 775.64K
EPS (Basic)
-8.73 -9.63 -8.66
EPS (Diluted)
-8.73 -9.63 -8.66
EBITDA
-10.65M -8.34M -6.61M
EBIT
-10.65M -8.34M -6.61M
Depreciation & Amortization
1.88K 1.98K 1.27K